In a special session of the executive board of the World Health Organization, Director-General Tedros Adhanom said that finger pointing will not save a single life. “We are all in this together. History will not judge us kindly if we invest millions and millions of dollars as our domestic stimulus …
Read More »
The Union Health Ministry has asked states to submit priority population lists that will receive the Covid-19 vaccine first by the end of October, Minister Harsh Vardhan said. The priority population refers to those who are at higher risk of contracting the virus than others. The government is working around …
Read More »
Amid growing concerns about the efficacy of Covid-19 vaccines in development, several participants in Moderna and Pfizer’s human trial program reported high fever, body aches, headaches, and exhaustion. However, these are common for any vaccine and are not a cause for alarm, experts have said. Here are the latest Covid-19 …
Read More »
In the ongoing race for an effective Covid-19 vaccine, several pharmaceutical companies are exploring out of the ordinary places. Johnson & Johnson is testing a single-shot vaccine, while traditional vaccine candidates require two injections. Bharat Biotech has announced the manufacture of an intranasal vaccine, which will differentiate it from intramuscular …
Read More »
When Johnson & Johnson announced the third phase of its Covid-19 vaccine clinical trial, US President Donald Trump said that four Covid-19 vaccine candidates are in the final stage. Here is the status of the ongoing trials Pfizer The candidate vaccine being developed by Pfizer and its German partner BioNTech …
Read More »
The Serum Institute of India is set to begin the final stage of the clinical trial of the experimental vaccine from the University of Oxford and AstraZeneca Plc., Starting next week. The last-stage trial will take place at Sassoon General Hospital in Pune, according to the news agency. PTI. “The …
Read More »
The Serum Institute of India said on Thursday it was halting the University of Oxford-Astrazeneca’s COVID-19 vaccine trial in India until the British-Swedish drugmaker restarts the trial. The move came a day after the Pune-based vaccine maker received a notice of demonstration cause from the Drugs General Inspector of India …
Read More »